Marc Veldhoen

Marc Veldhoen studied Medical Biology at Utrecht University and then moved to National Institute for Medical Research (Mill Hill), UK. From 2010 to 2016 he was a group leader at the Babraham Institute in Cambridge, UK. He was awarded a prestigious ERC consolidator grant and was selected for the European Molecular Biology Organisation young investigator programme. In 2016 he moved to the Instituto de Medicina Molecular (iMM) in Lisbon, Portugal as the European Research Area chair. Where from 2018 he took up a position as professor of basic immunology at Lisbon School of Medicine. His lab focus is T cell biology, with wide ranging interests from development and activation to differentiation, maintenance and metabolism. He made seminal contributions to CD4 T cell biology, such as the differentiation of Th17 and Th9 cells, and the role of the arylhydrocarbon receptor (AhR) in T cell biology. A large part of the lab is now dedicated to tissue resident T cells and the mechanisms that control their development, maintenance, and activation. The clinical benefits are targeting the prevention of undesirable immune responses that may result in chronic infections, allergies, and autoimmunity as well as strengthening our own immune responses against infection, such as using vaccination, as well as against tumours.